Thymidine (METHY1-3H) radioisotope, catalog# NET027005MC, (QTY 12 each @ $247.00= $2,964.00)

Ended Awarded

Contract number
HHSN27200026
Awardee
Awarding agency
Obligated
$3,264

Award facts

Contract value 50% obligated
  • $3,264.00 Current, with exercised options
  • $6,528.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract HHSN27200026?

HHSN27200026 was awarded to Revvity Health Sciences, Inc. by NIAID DEA OA Acquisitions (National Institutes of Health) on December 17, 2010.

How much is contract HHSN27200026 worth?

The government has obligated $3,264 on HHSN27200026. Its potential value, with all options, is $6,528.

Is contract HHSN27200026 an order under another contract?

Yes. HHSN27200026 is a BPA call under HHSN263199800049720B, a blanket purchase agreement.

Was contract HHSN27200026 competed?

The extent of competition for HHSN27200026 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award